Centene Faces Class Action Lawsuit for Alleged Securities Fraud.

A group lawsuit has been initiated against Centene Corporation, accusing the company of securities fraud and engaging in illegal business practices. This lawsuit involves investors who bought Centene securities between July 1, 2022, and July 1, 2025, giving them until September 8, 2025, to seek appointment as Lead Plaintiff. The lawsuit asserts that Centene and some of its officers and/or directors were involved in securities fraud or other illicit business practices. The complaint advises investors to contact Danielle Peyton at [email protected] or call 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980, to discuss the class action.

The legal action centers around Centene withdrawing its 2025 GAAP and adjusted diluted earnings per share (EPS) guidance on July 1, 2025. The company mentioned lower-than-expected market growth and higher healthcare risks in 22 out of 29 states within its market as reasons for the update. This disclosure led to a significant drop in Centene’s stock price, plummeting $22.87 per share, or 40.37%, to finish at $33.78 per share on July 2, 2025.

In a separate notice, The Gross Law Firm has reached out to shareholders of Centene Corporation, urging them to connect with the firm to potentially be appointed lead plaintiff. This class action lawsuit pertains to the period between December 12, 2024, and June 30, 2025. The firm alleges that Centene provided overly optimistic statements to investors while withholding crucial information or disseminating misleading statements about its enrollment and morbidity rates.

To participate in the class action, investors are urged to register their details by September 8, 2025, at no cost or obligation. Upon registration, shareholders will be included in a portfolio monitoring program to receive updates on the case’s progress. As of now, Centene Corporation has not issued any response to the allegations presented in the lawsuit. The company is under scrutiny for its financial performance and market expansion, prompting investors to follow the case’s developments closely and seek advice from legal and financial experts tailored to their individual situations.